Search - tctmd.com

Displaying 21 - 40 of 78

Sort: Relevancy | Date

News Daily News

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

L.A. McKeown

July 11, 2023

News Conference News LINC 2023

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

L.A. McKeown

June 09, 2023

News Conference News SCAI 2023

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

L.A. McKeown

May 31, 2023

News Conference News EuroPCR 2023

For Bifurcation Lesions, It’s OK to Start With Just One Stent: EBC Trials

Caitlin E. Cox

May 17, 2023

News Opinion CV Team Dispatch

March 2023 News Roundup

L.A. McKeown

March 15, 2023

News Daily News

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Michael O'Riordan

February 24, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Daily News

Brachytherapy Remains an Option for DES In-Stent Restenosis

Yael L. Maxwell

January 12, 2023

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

L.A. McKeown

July 18, 2022

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

News Conference News ACC 2022

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Michael O'Riordan

April 13, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2022

Caitlin E. Cox

April 01, 2022

News Conference News

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

Caitlin E. Cox

March 02, 2022

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

News Daily News

IVUS-Guided PCI Tied to Better Long-term Outcomes After Acute MI

Todd Neale

October 29, 2021

News Conference News TCT 2021

OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions

L.A. McKeown

October 25, 2021

News Conference News VIVA 2021

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

L.A. McKeown

October 12, 2021

News Conference News VIVA 2021

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

L.A. McKeown

October 08, 2021

News Daily News

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

L.A. McKeown

October 05, 2021

Advertisement

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

For Bifurcation Lesions, It’s OK to Start With Just One Stent: EBC Trials

March 2023 News Roundup

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

Brachytherapy Remains an Option for DES In-Stent Restenosis

High Lp(a) May Predict Risk of CV and Limb Events in PAD

More Support for Single Antiplatelet Therapy After TAVI

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

TCTMD’s Top 10 Most Popular Stories for March 2022

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

More DAPT Duration Data, More Calls to Tailor to Individual Patients

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

IVUS-Guided PCI Tied to Better Long-term Outcomes After Acute MI

OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content